IL-10 agonist

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

PD-L1 overexpression	Non Small Cell Lung Cancer	PD-L1 overexpression	Non Small Cell Lung Cancer	pembrolizumab + LY3500518 Resistant: C3 – Early Trials pembrolizumab + LY3500518 Resistant : C3	pembrolizumab + LY3500518 Resistant: C3 – Early Trials pembrolizumab + LY3500518 Resistant : C3
TMB-H	Non Small Cell Lung Cancer	TMB-H	Non Small Cell Lung Cancer	nivolumab + LY3500518 Sensitive: C4 – Case Studies nivolumab + LY3500518 Sensitive : C4	nivolumab + LY3500518 Sensitive: C4 – Case Studies nivolumab + LY3500518 Sensitive : C4

Associations(2)